Prescient Therapeutics Limited (ASX:PTX)

Prescient Therapeutics Revenue

Prescient Therapeutics had revenue of 1.16M AUD in the half year ending December 31, 2025, a decrease of -40.31%. This brings the company's revenue in the last twelve months to 4.27M, up 41.20% year-over-year. In the fiscal year ending June 30, 2025, Prescient Therapeutics had annual revenue of 4.36M with 17.35% growth.

• Revenue (ttm): 4.27M
• Revenue Growth: +41.20%
• P/S Ratio: 14.30
• Revenue / Employee: 1.42M
• Employees: 3
• Market Cap: 60.99M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	4.36M	644.03K	17.35%
Jun 30, 2024	3.71M	1.28M	52.89%
Jun 30, 2023	2.43M	538.79K	28.52%
Jun 30, 2022	1.89M	703.86K	59.37%
Jun 30, 2021	1.19M	156.14K	15.17%